Open Access

The future is now.

Topic: Atrial fibrillation (AF)
Sponsored by Boehringer Ingelheim

Presentation

About the speaker

Professor Christopher Paul Cannon

Cardiovascular Division, Brigham and Women?s Hospital, Harvard Medical School, Boston (United States of America)
30 presentations
0 follower

4 more presentations in this session

Anticoagulation 3.0: the first NOAC with a reversal agent.

Speaker: Doctor J. Weitz (Hamilton, CA)

Thumbnail

Anticoagulation in the electrophysiology lab: how can specific reversal simplify care?

Speaker: Doctor H. Calkins (Baltimore, US)

Thumbnail

Anticoagulation post-PCI: case based discussion.

Speaker: Professor S. Hohnloser (Frankfurt, DE)

Thumbnail

Audience Q&A - The future is now: impact of oral anticoagulation reversal on your practice.

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Access the full session

The future is now: impact of oral anticoagulation reversal on your practice

Speakers: Professor C. Cannon, Doctor J. Weitz, Doctor H. Calkins, Professor S. Hohnloser, Professor G. Lip
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk